Merger and Acquisition Scenario
Valeant Pharmaceuticals Intl Inc (VRX) and Warner Chilcott Plc (WCRX)
| Date: | Feb 04, 2012 |
|---|---|
| Format: | HTML |
| Price: | $250.00 |
Abstract
Revere Data's Merger & Acquisition Scenario Report offers independent, objective and insightful analysis into a hypothetical combination of Valeant Pharmaceuticals Intl Inc (VRX) with Warner Chilcott Plc (WCRX) . The Revere report begins by identifying Valeant Pharmaceuticals Intl Inc products that are either complementary or overlapping to Warner Chilcott Plc products. Valeant Pharmaceuticals Intl Inc suppliers are then displayed alongside Warner Chilcott Plc suppliers, with overlapping suppliers to both firms highlighted. Dependent suppliers to both companies are also displayed, including the percentage of dependent revenue if known. Top Valeant Pharmaceuticals Intl Inc customers and top Warner Chilcott Plc customers, including overlapping customers, are also shown. The Revere report then includes key business relationship data in the area of strategic partnerships for each company. Additional content and features include Lines of Business Summaries, Product Summaries, Individual Valeant Pharmaceuticals Intl Inc Product Line and Warner Chilcott Plc Product Line Details, Valeant Pharmaceuticals Intl Inc Earnings and Warner Chilcott Plc Earnings Summaries, and pro forma financial statements. Revere Data Merger & Acquisition Scenario Reports are an essential source of competitive insight into an array of potential merger, acquisition, takeover, consolidation, rollup or other combination scenarios, with particular focus in the healthcare, biotechnology, information technology, finance and media sectors. Revere's extensive databases on key business relationships, product lines, focused sectors, and financial performance indicators provide a rich and integrated information source for investment banking, corporate finance, C-level executives, management consultants, marketing, and business intelligence professionals who want actionable answers and ideas in seconds.
Report Contents
- Summary
- Lines of Business Summary
- Product Summary
- Overlap & Complementary Sectors
- Sample Products in Similar Lines of Business
- Sample Products in Complementary Lines of Business
- Business Relationship Summary
- Top Key Suppliers
- Top Key Customers
- Key Financial Summary
- Individual Company Summary
- Focused Sector
- Revenue/Earnings Summary
- Business Description
- Product Summary
- Product Details
- Relationship Details
- Key Competitors
- Dependent Suppliers
- Key Customers
- Key Partners
- Financials
- Income Statement
- Balance Sheet
- Cash Flow
Companies Mentioned in the Report
- Valeant Pharmaceuticals Intl Inc (VRX) - Overview - Reports
- Warner Chilcott Plc (WCRX) - Overview - Reports
More Information:
Learn more about Merger and Acquisition Scenario Report.
Don't see the Scenario report you want? Request Merger and Acquisition Scenario Report »
Download Fact Sheet Merger and Acquisition Scenario (PDF)
Related Reports:
- Merger and Acquisition Scenario for Warner Chilcott Plc (WCRX) and Valeant Pharmaceuticals International (VRX)
- Merger and Acquisition Scenario for AstraZeneca plc (ADR) (AZN) and Valeant Pharmaceuticals Intl Inc (VRX)
- Merger and Acquisition Scenario for Meldex International Plc (MLGGY) and Valeant Pharmaceuticals International (VRX)
- Merger and Acquisition Scenario for Alnylam Pharmaceuticals, Inc. (ALNY) and Valeant Pharmaceuticals International (VRX)